In Brief
Th1 cells are known for their enhanced stability, so mechanisms that mediate their flexibility are poorly studied. Here, Stathopoulou et al. demonstrate that plasticity of Th1 cells to Tbet + iTreg cells is mediated by PD-1 signaling via asparaginyl endopeptidase (AEP). AEP inhibition enhanced iTreg cells in GvHD and tumor models.
SUMMARY CD4 + T cell differentiation into multiple T helper (Th) cell lineages is critical for optimal adaptive immune responses. This report identifies an intrinsic mechanism by which programmed death-1 receptor (PD-1) signaling imparted regulatory phenotype to Foxp3 + Th1 cells (denoted as Tbet + iTreg PDL1 cells) and inducible regulatory T (iTreg) cells. Tbet + iTreg PDL1 cells prevented inflammation in murine models of experimental colitis and experimental graft versus host disease (GvHD). Programmed death ligand-1 (PDL-1) binding to PD-1 imparted regulatory function to Tbet + iTreg PDL1 cells and iTreg cells by specifically downregulating endolysosomal protease asparaginyl endopeptidase (AEP). AEP regulated Foxp3 stability and blocking AEP imparted regulatory function in Tbet + iTreg cells. Also, Aep À/À iTreg cells significantly inhibited GvHD and maintained Foxp3 expression. PD-1-mediated Foxp3 maintenance in Tbet + Th1 cells occurred both in tumor infiltrating lymphocytes (TILs) and during chronic viral infection. Collectively, this report has identified an intrinsic function for PD-1 in maintaining Foxp3 through proteolytic pathway.
INTRODUCTION
Functional plasticity of cells belonging to the innate and adaptive immune system is necessary for the generation of robust immune responses while minimizing detrimental effects toward the host. CD4 + T cell plasticity has been extensively studied in recent years (O'Shea and Paul, 2010) . A plasticity index has been proposed for the various T helper cell lineage subsets, with each subset possessing different lineage flexibility (Murphy and Stockinger, 2010) . Of the numerous CD4 + T cell subsets, peripherally generated T regulatory (Treg) cells and T helper (Th) 17 cells are regarded as plastic (Bailey-Bucktrout et al., 2013; Boniface et al., 2010; Gagliani et al., 2015; McGeachy et al., 2007; Mukasa et al., 2010; Yang et al., 2008) whereas functional stability has been attributed toward thymic derived Treg (tTreg) cells (Miyao et al., 2012) , Th1, and Th2 cell lineages. Both Th2 cells (Adeeku et al., 2008; Hegazy et al., 2010; Peine et al., 2013; Taylor et al., 2006) and tTreg cells (Feng et al., 2014; Laurence et al., 2012; Zhou et al., 2009 ) have been demonstrated to be plastic in disease conditions. In light of these studies, Th1 cells remain the lineage with the least evidence of functional flexibility. Furthermore, the molecular mechanisms that influence lineage stability in Th1 cells are poorly defined (Brown et al., 2015) .
In contrast to work on cytokine signaling (O'Shea and Paul, 2010) , the role of co-receptors in mediating functional plasticity has received minimal attention. One such co-inhibitory molecule that has been implicated in Th cell plasticity is programmed death ligand-1 (PDL-1 or B7-H1). In our previous work, we have found that PDL-1 can induce Foxp3 in human Th1 cells (Amarnath et al., 2011) , consistent with work in murine naive T cells (Francisco et al., 2009 ). In the tumor microenvironment, PDL-1 expression coincides with increased intra-tumor Foxp3 + T cells (Duraiswamy et al., 2013; Jacobs et al., 2009) , suggesting that PDL-1 may play a role in maintaining Foxp3 expression in CD4 + Th cell subsets. PDL-1 binds to its receptor PD-1 on T cells which signals through the inhibitory phosphatase SHP1 (Chemnitz et al., 2004) . SHP1 or SHP2 recruitment results in STAT de-phosphorylation (Amarnath et al., 2011; Taylor et al., 2017) , potentially destabilizing the transcriptional signature of Th1 cell lineage.
In the current study, we have elucidated an intrinsic mechanism by which PD-1 signaling maintains Foxp3 in Tbet + iTreg and iTreg cells. The data presented here demonstrate that PD-1 can inhibit a functional nuclear pool of active asparaginyl endopeptidase (AEP), an endo-lysosomal protease previously implicated in antigen processing in dendritic cells (Dall and Brandstetter, 2016; Manoury et al., 1998 Manoury et al., , 2002 . We show that AEP is responsible for destabilizing Foxp3 in both iTreg and Tbet + iTreg cells. We found that PD-1 activation significantly enhanced Foxp3 expression in primed anti-viral and anti-tumor Tbet + Th1 cells, which was reversed in the presence of a blocking antibody to PDL-1. Of note, PDL-1 blockade did not reverse Tbet + Th1 cell conversion and iTreg cell induction in the absence of AEP. Therefore, this study demonstrates that downregulation of AEP is necessary for PD-1-generated Foxp3 stability.
RESULTS

PD-1 Signaling, in the Absence of TGF-b1, Reinforces Foxp3 Expression in CD4
+ Tbet + Foxp3 -T Cells
To investigate whether PD-1 maintains Foxp3 in Th1 cells, previously described Tbx21ZsGreen reporter mice were crossed with Foxp3RFP mice. Flow sorted CD4 + Tbet + Foxp3 À T cells ( Figures   1A , 1B, S1A, and S1B) were differentiated under iTreg cell conditions (Tbet + iTreg cells) or iTreg cell conditions with PDL-1 (Tbet + iTreg PDL1 cells) ( Figures 1A-1D ). When subsets were maintained with interleukin-2 (IL-2) and transforming growth factor-b (TGF-b1), Foxp3 expression under both culture conditions was similar ( Figure 1D ). In culture conditions where TGF-b1 was omitted from day 4 until day 7 ( Figure 1E ), a significant loss in Foxp3 was noted within the Tbet + iTreg cells compared with Tbet + iTreg PDL1 cells (Figures 1F and 1G Experiments were repeated at least five times and each experiment was performed with n = 5-9 mice. Cumulative data from all experiments are presented. Mean ± SEM. Please also refer to Figure S1 . In order to identify PD-1-dependent molecular mechanism that was operational in Tbet + iTreg PDL1 cells, we first evaluated AKT and mTOR signaling pathway as previously reported in iTreg cells (Francisco et al., 2009) . No difference in the phosphorylation of AKT or mTOR pathway was observed ( Figure S3A ). Therefore, we next evaluated the gene expression profile of Tbet + iTreg
and Tbet + iTreg PDL1 cells. We found downregulation of a protease, namely asparaginyl endopeptidase (AEP), in Tbet + iTreg PDL1 cells using micro-array analysis ( Figure S3B ). Consistent with our microarray data, AEP protein expression ( Figure 3A ) and enzyme activity was significantly decreased in Tbet + iTreg PDL1 cells compared with Tbet + iTreg cells ( Figures S3C and S3D ). The active form of AEP was evaluated by using LE28 probe (which emits a fluorescent signal when ligated to the active form of AEP; Figure S3C ; Edgington et al., 2013) . We next evaluated whether a functional nuclear pool of AEP was available within Tbet + iTreg cells, as previously reported (Dall and Brandstetter, 2016; Haugen et al., 2013; Kosugi et al., 2009) , using LE28 by imaging flow cytometry. We found a significant increase in the presence of active nuclear AEP in Tbet + iTreg cells compared with Tbet + iTreg PDL1 cells (representative images in Figures 3B and 3C; summary of nuclear activity Figure S3E ). In addition, active AEP was expressed in iTreg cells generated in the absence of PDL-1, but not in polarized Th1, Th2, CD4
+ T cells ( Figures 3D and S3F ). PDL-1-treated iTreg cell cultures showed relatively diminished AEP activity, which was abrogated in Pd1 À/À iTreg cells ( Figures 3D and S3G ).
Finally, we evaluated the presence of nuclear AEP by immuno blotting and confocal microscopy. In all cases, we found AEP to be expressed within the nucleus in Tbet + iTreg and iTreg cells (Figures 3E and 3F) , which was limited by the addition of PDL-1 ( Figure 3F ). Using confocal microscopy and imaging flow cytometry on cells stained with fluorescent markers for Foxp3 protein and active nuclear AEP, we found that Foxp3 and AEP were co-localized in Tbet + iTreg cells and iTreg cells . This result prompted us to examine whether Foxp3 was a specific target of AEP or whether AEP indirectly regulated Foxp3 expression. Co-incubation of activated AEP with Foxp3 protein demonstrated that AEP directly cleaved Foxp3, but not T-bet protein ( Figure 3J ). In spite of possessing numerous asparaginyl sites, T-bet protein was refractory to AEP cleavage, whereas minimally cleaved Foxp3 bands (band 2 and 3) were noted by immuno blotting. However, band 3 was noted in conditions, which incorporated AEP inhibitor (Figures 3J). When we subjected band 2 and band 3 to high-throughput mass spectrometry, AEP-specific peptide cleavage product was found in band 2 and not band 3. Data from this analysis identified a specific semi-tryptic cleaved peptide within band 2 which was a target for AEP (N155; AEP cleaves after Asn [N] ). No other AEP-specific targets were identified within the two bands ( Figure 3K and Table S1 ). Figures S4C and S4D ). We tested whether the AEPresistant mutant Foxp3 had enhanced stability in in vitro experiments. WT and mutant 1 were transduced into HEK293T cells and then rate of Foxp3 degradation in the presence of AEP and AEP inhibitor was evaluated. AEP specifically degraded WT Foxp3 protein while showing no activity on mutated Foxp3 mutant 1 protein ( Figures S4E and S4F ). These in vitro experiments suggest that AEP may directly act on Foxp3 protein within T cells.
Deletion of AEP-Specific Cleavage Site in Foxp3 Results in Prevention of Alloreactive GvHD
We next evaluated the in vivo function of cells that were transduced with WT Foxp3 (mouse and human) or Foxp3 mutant 2 (human) and mouse Foxp3 mutant 1. For these experiments, we first constructed human WT and mutated Foxp3 (N154; Asn site is at 154 in human) as our mass spectrometry data were obtained from human Foxp3 protein. In addition, we also constructed WT and mutated (N153; Asn site is at 153 in mouse) mouse Foxp3. All the constructs were transduced into naive mouse T cells and Foxp3 expression was evaluated ( Figure 4A ), (H) Alloreactive IFN-g was measured using Luminex. Each experiment had n = 3-5 mice per cohorts. Data shown are cumulative from 2 independent experiments. For survival curve, each cohort consisted of n = 10 mice. Data are presented as mean ± SEM. Please also refer to Figure S2 .
and nuclear localization ( Figure S5A ) for each construct were verified at day 4 after transduction. The transduced WT and mutant forms of Foxp3 were functional as they suppressed the capacity of the transduced cells to produce IFN-g (IFN-g being a specific target of Foxp3 in vitro) ( Figure S5B ). The in vivo suppressive function of transduced T cells was tested in a murine GvHD model (Laurence et al., 2012) . We found that T cells transduced with mutated versions of Foxp3 (both mouse and human) significantly prevented GvHD lethality in murine recipients as compared to WT Foxp3 ( Figure 4B ). Figure 1E ). Certain culture conditions were supplemented with AEPi. We found that the AEPi cultures had significantly higher Foxp3 expression as compared to the control cultures, whereas no significant difference was noted in Aep À/À iTreg cell cultures, thus confirming the specificity of the AEP inhibitor ( Figures S5C and S5D (WT mFoxp3, 0.1 3 10 6 ) or murine mutant Foxp3 (N153; Mu mFoxp3, 0.1 3 10 6 ). GvHD lethality was monitored (n = 6 per cohort).
(C and D) Host BALB/c mice were subjected to TBI and then reconstituted with bone marrow (BM, 10 7 cells), CD4 + CD25 À T effector cells (CD45. Experiments were repeated twice with n = 4-6 mice for immunological studies and n = 6-10 mice for survival curve. Representative data from one experiment are shown as mean ± SEM. Please also refer to Figure S5 . (Hall et al., 2012; Koch et al., 2009 Koch et al., , 2012 Levine et al., 2017) propose that tTreg cells are the likely precursors of Tbet In vivo cell tracing experiments performed in the long-term colitis model highlights a mechanism by which PDL-1 imparts regulatory function to Tbet + iTreg PDL-1 cells. During colitis, Tbet + iTreg PDL-1 cells had sustained Foxp3 expression after 60 days in an inflammatory environment unlike their counterpart Tbet + iTreg cells. These data support a regulatory mechanism whereby differentiation of Tbet + cells in the presence of PDL-1 can result in sustained Foxp3 expression in vivo and led us to explore the molecular mechanisms by which PD-1 signaling regulated Foxp3 stability. We found a proteolytic pathway that was operational in maintaining Foxp3 protein stability in iTreg cells and Tbet + iTreg cells involving direct inhibition of the activity of AEP. PD-1 inhibition of AEP was independent of CD28 signaling (Hui et al., 2017; Kamphorst et al., 2017) . The notion that a specific protease can perform an essential specific proteolytic function is controversial as cells express many proteases that exhibit considerable functional redundancy (van Kasteren and Overkleeft, 2014) . However, cell type-specific differences in protease function have been previously reported. For example, AEP breaks down self-antigens in DCs (Manoury et al., 2002) and cathepsin G performs this function in B cells (Burster et al., 2004) . AEP activity has been reported both in lysosomes and in the nucleus of tumor cells (Haugen et al., 2013) . Functionally AEP can induce tumor cell proliferation and migration and process antigens for optimal presentation by DCs (Andrade et al., 2011; Lin et al., 2014; Manoury et al., 1998) . In contrast to other lysosomal proteases, AEP is expressed in the cytosol and nucleus and the activity of AEP across both neutral and acidic pH has been previously reported (Haugen et al., 2013) . These observations enable a mechanism by which Foxp3 in the nucleus can be targeted by AEP.
The imaging and biochemical data presented here demonstrated that in T cells, AEP played a specific function in cleaving Foxp3 but not Tbet. These results are in accordance with previous AEP studies where it has been shown that AEP substrates in part are not amenable to other protease activity. In addition, AEP is well known for its substrate and cleavage specificity and often AEP-mediated cleavage results in a functional immunological outcome in vivo (Manoury et al., 1998 (Manoury et al., , 2002 . In T cells, AEP adheres to this phenotype, whereby it specifically targets and cleaves Foxp3 at a single site, which results in the instability of the protein. Therefore, our study implicates the occurrence of a proteolytic-mediated regulation of Foxp3 in iTreg and Tbet + iTreg cells.
The data presented here postulate a post-translational mechanism of Foxp3 protein regulation in addition to the previously described proteosomal pathway that is operational in Foxp3 regulation. However, deleting AEP was sufficient for maintaining Foxp3 protein in iTreg and Tbet + iTreg cells in vivo. In contrast to the proteosomal degradation study where an shRNA approach was used (Chen et al., 2013; van Loosdregt et al., 2013; Zhao et al., 2015) , we have utilized a genetic loss-of-function model (Aep À/À mice) to demonstrate the stability of Foxp3 in vivo during acute inflammation. Furthermore, mutating AEP-specific sites in Foxp3 protected mice from GvHD-mediated lethality. Therefore, our data demonstrate that either AEP deficiency or Foxp3 mutated at AEP-specific sites can enhance Treg cell function and is a primary pathway in modulating post-translational stability of Foxp3 protein. Data are shown as mean ± SEM, from one representative experiment. Each experiment was repeated at least twice and had n = 5 mice for immunological studies or n = 10 for survival. Please also refer to Figure S6 . pTreg cell generation in chronic viral infection. In melanoma, Treg cell-mediated tolerance has largely been attributed to the migration of Treg cells from the periphery to the tumor site (Spranger et al., 2013) , while Tbet + Th1 cell conversion is largely unexplored. Since the microenvironment in melanoma provides an abundance of PDL-1 that can result in activation of PD-1 signaling on Tbet + TILs, we explored and found that Tbet + Th1 cell conversion indeed occurred. However, this study does not address the contribution of hematopoietic versus non-hematopoietic versus tumor tissue-derived PDL-1 in inducing Treg cell conversion within the tumor microenvironment. The results presented here raise the possibility that the PDL-1-driven Treg cell generation within the TILs is dependent on AEP expression and that individuals who overexpress AEP within their Treg TIL populations may be more responsive to PD-1-and/or PDL-1-based immunotherapeutics.
In conclusion, this report has identified a mechanism by which sustained PD-1 signaling induces robust regulatory function in iTreg cells through post-translational regulation of the Foxp3 protein. Therefore, this study demonstrates an insightful interaction between co-inhibitory receptor signaling and protease activity and has elucidated the importance of these two signaling pathways in maintaining T regulatory phenotype.
STAR+METHODS
Detailed methods are provided in the online version of this paper and include the following: B6.Foxp3RFP mice in a specific pathogen-free facility at the National Institutes of Health, USA and at Newcastle University, UK. B6.Tbx21ZsGreenFoxp3RFP mice were utilized for all T cell lineage-tracing experiments. The use of animals for this research was approved by the Animal Care and Use Committee, National Cancer Institute, and National Institute of Allergy and Infectious Diseases, NIH, and carried out in accordance with the NIH animal health and safety guidelines. Animal experiments conducted at Newcastle University were approved by the Newcastle Ethical Review committee and performed under a UK home office approved project license. Experimental methodology was in accordance to the NC3R recommendations and data are shown in accordance with ARRIVE guidelines.
STAR+METHODS KEY RESOURCE TABLE
METHOD DETAILS
Cell sorting and Flow cytometry and tetramer staining Unless stated otherwise, ZsGreen fluorescence was used to determine Tbet expression and RFP fluorescence was used to flow sort various cell populations. CD4 + Tbet + Foxp3 -Th cells were characterized by multi-parameter flow cytometry for surface markers. Cytokine phenotype of day 0 cells was measured by stimulating cells with phorbol-12-myristate 13-acetate (PMA) and ionomycin for four hours along with Golgiplug and Golgistop which was added in the last 2 hr of incubation. Flow cytometry staining antibodies for CD4 (clone: RM4-4), CXCR3 (clone: CXCR3-173), PD-1 (clone: 29F.1A12), PDL-1 (clone: 10F.9G2), CD44 (clone: IM7), CD45.1 (clone: A20), CD45.2 (clone: 104), H-2K b (AF6-88.5), CD62L (clone: MEL-14), CD8 (clone: 53-6.7), CCR4 (clone: 2G12), Neuropilin-1 (clone: 3E12), Helios (clone: 22F6), CD25 (clone: PC61) and CD127 (clone: A7R34) were purchased from BioLegend. Foxp3 (clone: FJK-16 s), IL-10 (clone: JES5-16E3), IFN-g (clone: XMG1.2) and Ki67 (clone: SolA15) were from Thermo Fisher Scientific. For MHC class I tetramer staining, H-2D b GP33-41 was used at 1:100 dilutions and staining was performed at 4 C for 1 hr. Data were acquired using either an LSR II or Fortessa or FACS CANTO and analyzed using FlowJo software version 9.6.4 or 10.0.6. 5 mg/ml) for 3 days in cell culture media [RPMI, supplemented with 10% FCS, glutamine (2 mM), non-essential amino acids (0.1 mM), 2-mercaptoethanol (50 mM), sodium pyruvate (1 mM), penicillin and streptomycin (100 IU/ml)] along with soluble anti-CD28 (clone:37.51;2 mg/ml), rmIL-2 (80 ng/ml), rhTGF-b1 (2 ng/ml), anti-IL-4 (BioLegend, clone:11B11;20 mg/ml) and anti-IFN-g (BioLegend, clone:XMG1.2; 20 mg/ml) with or without coated PDL-1fc chimera (5 mg/ml). After 3 days of culture, cells were expanded for an additional four days in the presence of IL-2 (80 ng/ml) and TGF-b1 (2 ng/ml) or with IL-2 alone. Cells were then characterized by intracellular flow cytometry for Foxp3 expression. Both populations were flow sorted for Foxp3 + cells and are denoted as Tbet + iTreg
and Tbet + iTreg PDL1 cells. Post-differentiation Tbet + iTreg and Tbet + iTreg PDL1 cells were stimulated overnight with anti-CD3 and anti-CD28 and then supernatants were subjected to a multiplex bead array luminex assay. Control populations of iTregs (iTreg and iTreg PDL1) were generated from CD4 + Tbet -Foxp3 -subsets, which were similarly cultured and characterized. Subsequently, expanded Foxp3 + cells from the various subsets were sorted and utilized in in vitro suppression assays and in vivo animal models of autoimmunity and alloimmunity. In certain experiments, CD4 + Tbet + Foxp3 -T helper cells were either cultured with AEP inhibitor MV026630 (100 mM) or AEP ShRNA or Vehicle (DMSO) from day 0 of culture in addition to anti-CD3, anti-CD28, rh-IL-2 and rh-TGF-b1 prior to being used as cellular therapeutics. In vitro Treg suppression assay CD4 + CD25 -cells were isolated using the Miltenyi Biotec Treg isolation kit and utilized in a Treg suppression assay as previously described (Thornton and Shevach, 1998) . Purified CD4 + CD25 -cells (5x10 4 ) were labeled with CellTrace Violet and then cultured in 96 well round bottom plates in 200 mL complete media along with 2x10 5 irradiated T cell-depleted spleen cells (3000 cGy) as accessory cells. Anti-CD3 (0.5 mg/ml) was added along with cultured flow sorted Foxp3 + iTreg populations (iTreg, iTreg PDL1 , Tbet + iTreg and Tbet + iTreg PDL1 cells) at the indicated ratios. Cells were incubated at 37 C for 72 hr and proliferation and suppression was monitored by flow cytometry. Proliferation of responder T cells was evaluated by CellTrace Violet dilution. Percent suppression of CD4 responder T cell was calculated with values representing the ratio of total divided peaks to both divided and non-divided peaks, normalized to the anti-CD3 alone experimental group. (1x10 5 ). Mice were weighed weekly and loss of body weight was used as an indicator of colitis. Immune endpoints were measured in the splenocytes and in LPL. LPL were isolated as previously described (Asseman et al., 1999) . Briefly, large intestine was digested using Liberase TL and DNase I followed by percoll gradient centrifugation. LPLs were washed twice with complete media and then used for immunological assays. Both splenocytes and LPL were stimulated with PMA and ionomycin along with GolgiPlug and Golgistop for 4 hr and then effector cytokines were measured by intracellular flow cytometry. Experimental Allogeneic GVHD BM was flushed from B6 donor femurs and tibias and T cell depleted (TDBM) using CD90.2 MACS beads (Miltenyi Biotec). Host allogeneic (BALB/c) female mice were conditioned with total body irradiation of 950 cGy in two divided doses three hours apart before being rescued with 10 7 TDBM cells together with 1x10 6 CD4 + CD25 -T cells from WT CD45.1 + B6 donors. In addition, various flow sorted iTreg populations (CD45.2 + ; 1x10 6 ) were adoptively transferred for prevention of GVHD. Survival was monitored as a measure of Treg cell potency. Alloreactive IFN-g was measured as follows: Single cell suspension of splenocytes (1x10 6 ) was cultured overnight with either syngeneic or allogeneic bone marrow derived dendritic cells DCs (1x 10 5 ). Supernatant was harvested at 24 hr and Th1 cytokines were measured by using a multiplex luminex bead array system. Allogenic IFN-g cytokine in the supernatant was measured by subtracting the amount of IFN-g present in the syngeneic controls. LCMV Six to eight weeks old B6.Tbx21ZsGreenFoxp3RFP mice were infected with Armstrong (2x10 5 PFU, i.p) or Clone-13 virus (2x10 6 PFU, i.v) as previously described (Wherry et al., 2003) . Titers of virus were determined by plaque assay on Vero cells as previously described (Ahmed et al., 1984) . At indicated time points, spleens were harvested and the frequency of Tbet and 9. Splenocytes and tumors were harvested at day 11 and the frequencies of Foxp3 + cells were evaluated.
In vivo animal models
Histological Analysis
Representative samples of liver, intestine and colon were obtained from the mice that underwent GvHD and fixed in 10% phosphate buffered formalin. Samples were embedded in paraffin, sectioned and stained with hematoxylin and eosin. All slides were coded and read by an external pathologist (Dr. Michael Eckhaus) in a blinded fashion. A four-point scale of GvHD severity was used to score the samples.
Affymetrix Gene Expression Profiling
Total RNA was isolated with RNAeasy kit from QIAGEN. RNA quality was checked on Agilent Bioanalyzer. All samples used for microarray analysis had high quality score (RIN > 9). 100 ng of RNA was reverse transcribed and amplified using Ambion WT expression kit following manufacturer's suggested protocol. Sense strand cDNA was fragmented and labeled using Affymetrix WT terminal labeling kit. Four replicates of each group were hybridized to Affymetrix mouse Gene ST 2.0 GeneChip in Affymetrix hybridization oven at 45 C, 60RPM for 16 hr. Wash and stain were performed on Affymetrix Fluidics Station 450 and scanned on Affymetrix GeneChip scanner 3000. Data were collected using Affymetrix AGCC software. Statistical and clustering analysis was performed with Partek Genomics Suite software using RMA normalization algorithm. Differentially expressed genes were identified with ANOVA analysis. Genes that are up-or downregulated more than 2 fold and with a p < 0.001 were considered significant.
Immuno Blotting
Protein lysates were obtained from Tbet + iTreg, and Tbet + iTreg PDL1 cells. Lysates were run on 10%-20% SDS-PAGE gels and transferred onto nitrocellulose membrane. Membranes were blocked with 5% milk in TBST buffer (20mmol/L TrisHCl, 500 mmol/L NaCl, and 0.01% and incubated overnight at 4 C with primary antibodies (Ab) in TBST containing either 5% milk or BSA. Immune reactivity was detected by sequential incubation with HRP-conjugated secondary Ab and enzymatic chemiluminescence (Cell Signaling Technology). Primary Abs to mouse PTEN, mTOR, phospho-mTOR, Akt, phospho-AKT (Ser473 and Thr 308), Foxp3, P70S6K, phospho-p70S6K, ERK, phospho-ERK, GAPDH, b-tubulin, b-actin were procured from Cell Signaling. AEP (Legumain) was obtained from R&D systems. Images were acquired using a LiCOR FcOdyssey system or Wes Simple Protein system. AEP enzyme activity AEP activity in cell lysates was measured in triplicates by cleavage of the substrate z-Ala-Ala-Asn-AMC (Bachem) as previously described (Haugen et al., 2013; Johansen et al., 1999) . Briefly, cell lysate (20 ml) was added to black 96-well microplates. After the addition of 100 mL buffer and 50 mL substrate solution (final concentration is 10 mM) at pH 5.8, a kinetic measurement based on increase in fluorescence over 10 min was performed at 30 C in a plate reader and presented as enzyme units where one unit of activity was defined as the amount of enzyme releasing 1.0 mmol of product/min under the standard conditions described. Enzyme activity was then normalized to the enzyme activity of DCs. DC enzyme activity was set to 100% and then the % enzyme activity of Tbet + iTreg and Tbet + iTreg PDL1 cells was calculated. Enzyme activity was also measured by using imaging flow cytometry using the AEP probe LE28 (Edgington et al., 2013) . LE28 specifically binds to active AEP enzyme. Briefly, Tbet + iTreg and Tbet + iTreg PDL1 cells were incubated with the AEP probe LE28 cy5 for 1 hr at 37 C, washed and then AEP activity was measured using flow cytometry.
Foxp3 co-localization Assays
The co-localization of Foxp3 in the nucleus was measured using imaging flow cytometry on the Amnis Image stream MKII. For this, cells were fixed and then stained with DAPI, Foxp3 APC and LAMP-1 APC-Cy7 (BioLegend, clone 1D4B). For co-localization experiments with AEP cells were stained with DAPI, Foxp3 PE, LAMP-1 APC-Cy7, and LE28 Cy5.
Amnis Imaging Flow cytometry
Sample Acquisition: Samples were run on an Image StreamX MKII using INSPIRE data acquisition software (Amnis EMD-Millipore) at a concentration of approximately 1x10 6 cells in 50 mL of PBS. The system was outfitted with 2 cameras, 12 channels, 405, 488, 561, 642, and 785nm lasers, and an extended depth of field element (EDF). Brightfield was collected in channels 1 and 9, SSC was collected in channel 6 at a 785nm power of 2mW, DAPI was detected in channel 7 (430-505nm filter) at a 405nm laser power of 10mW, TbetZsgreen was detected in channel 2 (480-560nm filter) at a 488 laser power of 20mW, Foxp3 PE was detected in channel 3 (560-595 filter) at a 561nm laser power of 200mW, and LE28 Cy5 were detected in channel 11 (660-745nm filter) and LAMP1 APC-Cy7 was detected in channel 12 (745-800nm filter) respectively, at a 642nm laser power of 150mW. Acquisition gates in INSPIRE were set as follows: a single cell gate was set on a Brightfield Area versus Brightfield Aspect Ratio plot to encompass single cells and eliminate debris and aggregates, a Brightfield Gradient RMS plot was used to gate single cells which were in focus, and gates were set in Raw Max Pixel plots to eliminate events saturating the camera in each fluorescent channel used. 20,000 single, focused, non-saturating events were acquired at 60X magnification, using the EDF element. Data Analysis: Data analyses were performed in IDEAS 6.0 software (Amnis EMD-Millipore). A compensation matrix was created utilizing single color controls acquired with Brightfield and the 785 laser turned off, and all others laser powers set to the powers listed above. In IDEAS, single, focused, and nucleated (DAPI + ) cells were gated and used for downstream analysis.
Determination of Foxp3 in the nucleus:
A series of masks was created which enabled the determination of the amount of Foxp3 in the nucleus. First, a tight mask was created on the nuclear image by eroding the default mask in one pixel (Erode (M07, 1). Next, a mask was created which identified Foxp3 staining (Intensity (M11, 11_Foxp3, 100-4095) ). Lastly, a mask was created to identify pixels which contained DAPI staining and Foxp3 staining by combining the aforementioned masks with an AND operator ((Erode (M07, 1) And Intensity(M11, 11_Foxp3, 100-4095)). The area of Foxp3 inside the nucleus was determined by creating an Area feature on the combined DAPI:Foxp3 mask and gating the Area plot on DAPI +
Foxp3
+ cells.
Determination of Foxp3 and AEP co-localization in the nucleus:
A series of masks was created which enabled the determination of the co-localization of Foxp3 and AEP in the nucleus. First, a mask was created which identified Foxp3 staining (Intensity (M03, 3_Foxp3, 300-4095). Next, a mask was created which identified AEP staining (Intensity (M11, 11_Legumain/AEP, 362-4095). The DAPI mask used is as described in the section above. Lastly, a mask was created to identify pixels which contained DAPI, Foxp3, and AEP staining by combining the aforementioned masks with an AND operator (Intensity (M03, 3_Foxp3, 300-4095) AND (Erode (M07, 1) AND Intensity (M11, 11_Legumain). The area of the pixels containing DAPI, Foxp3, and AEP staining was determined by creating an Area feature on the combined DAPI:Foxp3:AEP mask and gating the Area plot on DAPI + Foxp3 + AEP + cells. PDL1 were first stained with AEP Cy5 followed by fixation and permeabilization. Cells were washed with permeabilization buffer and then stained with Foxp3 PE and DAPI. Images were acquired on a Leica SP8 point scanning confocal microscopy with white light super continuum lasers. Colocalization analysis were performed as previously described (Dunn et al., 2011) . A comprehensive explanations of the confocal analysis is provided below:
Orthogonal projection view to enhance visualization of protein spatial location: An orthogonal projection of the image allows identification of the spatial location of a protein within the cell. It is a three-dimensional view of the cell but in a two-dimensional figure. A quadrant was drawn on a particular point in the nucleus, if all three fluorophores are present together in this 3D view, then the analysis shows this on merging the three images.
Deconvolution of the images to enhance signal to noise ratio in an orthogonal projection: Deconvolving is a recognized image processing technique to digitally reassign out of focus light to its originating focal plane. Deconvolution corrects optical aberration and provide higher resolution which enhances signal to noise ratio therefore minimizing false positive analysis. Combining deconvolution and orthogonal projection enhances understanding of the spatial location and co-localization of proteins within a cell.
Particle Analysis: Particle analysis was performed with the deconvolved images as recently shown (Kwon et al., 2017) . Using this technique, we measured the number of Foxp3 and AEP particles within the nucleus. We next performed a quantitative analysis of the particles and plotted the values as follows: Each data point depicts the number of particles within the nucleus and the y axis denotes the relative volume of Foxp3 within the nucleus and similarly the relative volume of AEP within the nucleus. If cytosolic contamination occurs, it will be represented in this analysis as follows. 100% on y axis denotes that the entire particle is within the nucleus whereas 20% denotes a particle that does not explicitly localize in the nucleus.
We next quantitatively measured AEP and Foxp3 co-localization. Each data point depicts the number of particles within the nucleus that is colocalized and the y axis denotes the value which is the sum of the intensity of all voxels that colocalize with each other.
Foxp3 cleavage and Mass Spectrometry
Human Foxp3 protein and Tbet protein was purchased from Origene and then used in the cleavage assay in the presence of purified AEP protein (kindly provided by Dr. Colin Watts). Briefly, 1 mg of human AEP protein was incubated in 200 mL of activation buffer (0.1M NaCl, 0.1M NaOAc, pH 4.5) in 96 well round bottom plates for 30 mins at 37 C. In certain conditions, the AEP inhibitor was added (100 mM). Post AEP activation, either Foxp3 protein (5 mg) or Tbet protein (5 mg) was added to the wells with only activation buffer or activation buffer plus AEP or activation buffer plus AEP plus inhibitor. The plate was then incubated for 2 hr at 37 C. Samples were then reduced with LDS sample buffer and then subjected to immuno blotting. Once the proteins were run on a gel, they were transferred to a membrane and blotted for Foxp3 and Tbet. In separate experiments, gels were stained with Coomassie blue (Gel Code Blue reagent; Thermo Fisher Scientific) and then bands were cut out and subjected to mass spectrometry as previously described (Zhang et al., 2014) . Briefly, bands were dehydrated using acetonitrile followed by vacuum centrifugation, reduced with 10 mM dithiothreitol and alkylated with 55 mM iodoacetamide. Gel pieces were then washed alternately with 25 mM ammonium bicarbonate followed by acetonitrile. Samples were digested with trypsin overnight at 37 C. Digested samples were analyzed by LC-MS/MS using an UltiMate Ò 3000 Rapid Separation LC (RSLC, Dionex Corporation, Sunnyvale, CA) coupled to an Orbitrap Elite (Thermo Fisher Scientific, Waltham, MA) mass spectrometer. Peptide mixtures were separated using a gradient from 92% A (0.1% FA in water) and 8% B (0.1% FA in acetonitrile) to 33% B, in 44 min at 300 nL min -1 , using a 75 mm x 250 mm i.d. 1.7 mM CSH C18, analytical column (Waters). Peptides were selected for fragmentation automatically by data dependent analysis. Data produced were searched using Mascot (Matrix Science UK), against the SWISSPROT database. Data were validated using Scaffold (Proteome Software, Portland, OR). Additional Foxp3 degradation experiments were performed with WT or mutated Foxp3 expressing 293 cells. The WT Foxp3 cDNA was isolated from a BamH1 + Xho1 digest of plasmid purchased from Addgene. The Mu Foxp3 containing alanine substituted for asparagine was synthesized by Integrated DNA Technologies custom gene synthesis service. The construct contained BamH1 and Xho1. These sites were used to clone both WT and mutant Foxp3 cDNAs into pCDNA3.1 and pEV Thy1.1 RV. The mutant Foxp3 construct also included a Not1 site to identify recombinant plasmids. The Foxp3 mutant cDNA was fully sequenced prior to use in experiments.
Pulse Chase Assays for Foxp3 protein turnover Tbet + iTreg and Tbet + iTreg PDL1 cells were washed and then aliquoted into 24 well tissue culture plates at 3x10 6 /ml. In certain experiments, WT or Aep À/À iTregs were plated into 24 well plates at 1x10 6 /ml. Cells were treated with cycloheximide (150 mg/ml) for the indicated time points and lysates were used to measure Foxp3 and Tbet protein degradation by immuno blotting. In order to block proteosomal degradation of Foxp3 and Tbet, MG132 (0.5 mM, Sigma-Aldrich) was added to certain culture conditions. AEP inhibitor MV026630 (100 mM, kindly provided by Prof. Colin Watts and Dr. Sander I. van Kasteren) was added to cultures to block specific AEP mediated degradation of Foxp3.
AEP and Foxp3 silencing and mutation assays AEP specific shRNAs were obtained from Origene. On confirming efficient silencing of AEP in NIH 3T3 cells, the most efficient shRNA was chosen for further analysis. Single-stranded oligonucleotides containing shRNA targeted to AEP or scrambled sequence, 20 bp complementary to the sequence flanking a Xho1 site within with the expression vector pEV Thy1.1 RV (gift from Dr. Vanja Lazarevic, NCI, NIH), and a Not1 site were purchased from IDT and annealed in buffer containing 1 mM Tris pH 8.0, 50 mM NaCl and 1 mM EDTA. The vector pEV Thy1.1 RV was digested with Xho1. The vector and the double stranded oligos were combined and a Gibson reaction (New England Biolabs) was performed. Recombinant clones were identified by Not1 restriction analysis. The integrity of the insert sequence and orientation was confirmed by DNA sequencing. Silencing of AEP was further confirmed in 3T3 cells and then was used to silencing AEP in primary murine Tbet + iTreg cells. pENTR Foxp3 was a gift from Prof. Anjana Rao [Addgene plasmid # 16363 (Wu et al., 2006) ] containing WT human Foxp3 cDNA that was cloned into pEV-Thy1.1-RV using BglII and Xho1. The AEP resistant human Foxp3 was synthesized as a mini-gene (IDT) and cloned into the BglII and Xho1 sites of pEV-Thy1.1-RV. The N154A human Foxp3 mutant was created by inserting a 240 bp G-Block DNA fragment (IDT) between the Bcl1 and BstB1 sites using the Gibson reaction (New England Biolabs). AEP cDNA was obtained from Prof. Colin Watts and cloned into pEV-Thy1.1-RV using Xho1. For NLS experiments AEP NLS site was mutated whereby KRK was replaced to AAA at site 318-320. pMIGR-mFoxp3 was a gift from Prof. Dan Littman (Addgene plasmid # 24067, unpublished). The N153A mutant was created by inserting a 182 bp G-Block DNA fragment (IDT) between the Bcl1 and BamH1 sites using the Gibson reaction (New England Biolabs). All modified constructs were verified by sequencing before use.
Retroviral transductions of Tbet + iTreg cells were performed as follows. Briefly, cells were stimulated for 24 hr and then washed once. Cells (0.5x10 6 ) were spin inoculated with 1ml of virus supernatant in the presence of polybrene (4 mg/ml) consisting of scramble or AEP shRNA for 50 mins at 3000RPM. The cells were then placed at 37 C for 2 hr after which an additional 2ml of complete RPMI media was added. Infection was monitored after 4 days as the percent of CD90.1 and AEP cy5 expression by flow cytometry. CD90.1 + Foxp3 + Tbet + iTreg cells were flow sorted and then adoptively transferred in to a murine model of allogeneic GVHD and in vivo stability of Foxp3 in Tbet + iTreg cells was monitored.
QUANTIFICATION AND STATISTICAL ANALYSIS
Statistical analysis was determined using GraphPad Prism 7 software. For experiments where two groups were compared, a twotailed Student's t test was performed. For comparison of three or more groups, a one-way ANOVA was performed followed by appropriate multiple comparison tests. For survival curve analysis, Kaplan-Meier survival curve analysis followed by a log rank test was performed. Unless stated otherwise, histogram columns represent the mean values for each experiment and error bars indicate the standard error of the mean. Data presented were considered significant if p value was % 0.05.
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